Mark R. Palmert, Canada

The Hosp for Sick Children Peidatrics
Mark Palmert graduated from the Medical Scientist Training Program at Case Western Reserve University, Cleveland, Ohio, with a MD and PhD in 1992. He completed his pediatrics and pediatric endocrinology training at the Children's Hospital, Boston, where he remained on staff until 2001. He returned to Cleveland to join the staff at the Rainbow Babies and Children's Hospital but then moved to Toronto in 2007 to become Head of the Division of Endocrinology at The Hospital for Sick Children (SickKids). In 2018, he transitioned to a new role as Associate Chair of Pediatrics for Ambulatory Care at SickKids. Mark has an active endocrinology practice that includes care of children and youth with type 1 and type 2 diabetes mellitus, and he has a long standing interest in designing and testing apps that have been created to help youth with self-management of diabetes.

Presenter of 1 Presentation

PARALLEL SESSION

iSpy: Novel Carbohydrate Counting Smartphone App for Youth with Type 1 Diabetes

Abstract

Abstract Body

Background: Accurate carbohydrate counting is an important aspect of diabetes management, but it can be challenging. iSpy is a novel mobile application designed to assist with carbohydrate counting by using machine learning to identify foods through images. Our objective was to evaluate iSpy’s usability and potential impact on carbohydrate counting accuracy.

Methods: For usability testing, three iterative cycles were conducted involving a total of 16 individuals (aged 8.5-17.0 years) with type 1 diabetes. Participants used iSpy to complete tasks while thinking aloud. Errors were noted, acceptability was assessed, and refinements were made before moving on to the next cycle. Next, iSpy was evaluated in a pilot randomized controlled trial with 22 iSpy users and 22 usual care controls aged 10-17 years. Primary outcome was change in carbohydrate counting ability over 3 months. Secondary outcomes included engagement, acceptability, and change in HbA1c level.

Results: After 3 cycles of usability testing, no errors occurred that prevented a user from completing a task. For the pilot RCT, use of iSpy was associated with improved carbohydrate counting accuracy (total grams per meal, P=.008), reduced frequency of individual counting errors greater than 10 g (P=.047), and lower HbA1c levels (P=.03). Qualitative interviews and acceptability scale scores were positive. No major technical challenges occurred. Moreover, 43% (9/21) of iSpy participants were still engaged, with usage at least once every 2 weeks, at the end of the study.

Conclusions: Our results provide evidence of efficacy and acceptability of a novel carbohydrate counting application, supporting the advancement of digital health apps for diabetes care among youth with type 1 diabetes. Further testing is needed, but iSpy may be a useful adjunct to traditional diabetes management.

Hide